These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2264065)

  • 1. Standardization of assays for testing the neutralizing ability of antivenoms.
    Gutiérrez JM; Rojas G; Lomonte B; Gené JA; Chaves F; Alvarado J; Rojas E
    Toxicon; 1990; 28(10):1127-9; author reply 1129-32. PubMed ID: 2264065
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on "Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms".
    da Silva WD; Tambourgi DV
    Toxicon; 2011 Jun; 57(7-8):1109-10. PubMed ID: 21524658
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of four different immunogens for the production of snake antivenoms.
    Li Q; Ownby CL
    Toxicon; 1992 Nov; 30(11):1319-30. PubMed ID: 1485332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical assessment of the neutralizing efficacy of snake antivenoms in Latin America and the Caribbean: A review.
    Gutiérrez JM
    Toxicon; 2018 May; 146():138-150. PubMed ID: 29510161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
    Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the preclinical efficacy of antivenoms: from the lethality neutralization assay to antivenomics.
    Gutiérrez JM; Solano G; Pla D; Herrera M; Segura Á; Villalta M; Vargas M; Sanz L; Lomonte B; Calvete JJ; León G
    Toxicon; 2013 Jul; 69():168-79. PubMed ID: 23201503
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Gutiérrez JM; Vargas M; Segura Á; Herrera M; Villalta M; Solano G; Sánchez A; Herrera C; León G
    Front Immunol; 2020; 11():617429. PubMed ID: 33505403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead.
    Gutiérrez JM; Solano G; Pla D; Herrera M; Segura Á; Vargas M; Villalta M; Sánchez A; Sanz L; Lomonte B; León G; Calvete JJ
    Toxins (Basel); 2017 May; 9(5):. PubMed ID: 28505100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-neutralization by tiger snake (Notechis scutatus) antivenene and sea snake (Enhydrina schistosa) antivenene against several sea snake venoms.
    Baxter EH; Gallichio HA
    Toxicon; 1974 May; 12(3):273-8. PubMed ID: 4218381
    [No Abstract]   [Full Text] [Related]  

  • 10. Snake venom hemorrhagins: neutralization by commercial antivenoms.
    Mebs D; Pohlmann S; Von Tenspolde W
    Toxicon; 1988; 26(5):453-8. PubMed ID: 2460973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-neutralization of thrombin-like enzymes in snake venoms by polyvalent antivenoms.
    Claus I; Mebs D
    Toxicon; 1989; 27(12):1397-9. PubMed ID: 2629180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross neutralization of coral snake venoms by commercial Australian snake antivenoms.
    Ramos HR; Vassão RC; de Roodt AR; Santos E Silva EC; Mirtschin P; Ho PL; Spencer PJ
    Clin Toxicol (Phila); 2017 Jan; 55(1):33-39. PubMed ID: 27595162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological studies on an Egyptian bivalent Naja antivenin.
    Mohamed AH; Darwish MA; Hani-Ayobe M
    Toxicon; 1974 May; 12(3):321-3. PubMed ID: 4458113
    [No Abstract]   [Full Text] [Related]  

  • 14. Cross neutralization of common Southeast Asian viperid venoms by a Thai polyvalent snake antivenom (Hemato Polyvalent Snake Antivenom).
    Leong PK; Tan CH; Sim SM; Fung SY; Sumana K; Sitprija V; Tan NH
    Acta Trop; 2014 Apr; 132():7-14. PubMed ID: 24384454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new ELISA for determination of potency in snake antivenoms.
    Rial A; Morais V; Rossi S; Massaldi H
    Toxicon; 2006 Sep; 48(4):462-6. PubMed ID: 16893558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms.
    Segura A; Castillo MC; Núñez V; Yarlequé A; Gonçalves LR; Villalta M; Bonilla C; Herrera M; Vargas M; Fernández M; Yano MY; Araújo HP; Boller MA; León P; Tintaya B; Sano-Martins IS; Gómez A; Fernández GP; Geoghegan P; Higashi HG; León G; Gutiérrez JM
    Toxicon; 2010 Nov; 56(6):980-9. PubMed ID: 20621114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein content of antivenoms and relationship with their immunochemical reactivity and neutralization assays.
    de Roodt AR; Clement H; Dolab JA; Litwin S; Hajos SE; Boyer L; Alagón A
    Clin Toxicol (Phila); 2014 Jul; 52(6):594-603. PubMed ID: 24940642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms.
    León G; Herrera M; Segura Á; Villalta M; Vargas M; Gutiérrez JM
    Toxicon; 2013 Dec; 76():63-76. PubMed ID: 24055551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Application of Snake Venom Proteomics in In Vivo Antivenom Assessment.
    Tan CH; Tan KY
    Methods Mol Biol; 2019; 1871():153-158. PubMed ID: 30276739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New techniques in antivenom production and active immunization against snake venoms.
    Theakston RD
    Trans R Soc Trop Med Hyg; 1989; 83(4):433-5. PubMed ID: 2694474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.